Skip to main content
. 2024 Mar 7;137(3):73. doi: 10.1007/s00122-024-04577-1

Table 2.

QTLs found across multiple trials using the NIAB_WW_SHW_NAM population for flowering time (Ft), plant height (Ph) and yellow rust infection (Yr)

QTL Trait Trial n Sig. threshold Genetic marker Chr Peak Position (Mb) –log10(P) Alt. allele effect Var. (%)
QFt.niab-2B.1 Ft Core19 596 4.86 AX.94970315 2B 26.6 6.34 − 0.96 0.84
QFt.niab-2B.1 Ft Full21 2389 4.97 AX.95082190 2B 58.1 6.25 − 0.99 1.10
QFt.niab-2D.1 Ft Core19 596 4.86 AX.94779177 2D 14.9 5.33 − 0.86 0.04
QFt.niab-2D.1 Ft Core21 277 4.66 AX.94603120 2D 33.4 10.74 − 1.77 10.75
QFt.niab-4A.1 Ft Core18 852 4.66 AX.94552332 4A 735.8 10.09 − 0.68 0.18
QFt.niab-4A.1 Ft Full21 2389 4.97 AX.95165912 4A 681.4 10.31 − 0.84 0.86
QFt.niab-7D.1 Ft Core18 852 4.66 AX.95229555 7D 17.8 8.50 − 0.62 0.03
QFt.niab-7D.1 Ft Core20 457 4.66 AX.94929727 7D 61.2 5.87 − 1.06 5.07
QFt.niab-7D.1 Ft Full21 2389 4.97 AX.94688897 7D 32.0 5.33 − 0.59  < 0.01
QPh.niab-5A.2 Ph Core18 852 4.66 AX.94462177 5A 527.9 8.52 2.25 0.34
QPh.niab-5A.2 Ph Full21 2389 4.97 AX.94462177 5A 527.9 5.36 1.50 1.07
QPh.niab-6A.1 Ph Core17 253 4.46 AX.94474129 6A 114.2 6.18 3.61 0.87
QPh.niab-6A.1 Ph Core18 852 4.66 AX.95630086 6A 230.7 12.63 3.18 3.28
QPh.niab-6A.1 Ph Core21 277 4.66 AX.95630086 6A 230.7 6.73 4.25 9.81
QPh.niab-6A.1 Ph Full21 2389 4.97 AX.95159326 6A 405.4 19.10 3.06 2.45
QPh.niab-6D.1 Ph Core17 253 4.46 AX.94940605 6D 84.3 6.06 3.43 0.99
QPh.niab-6D.1 Ph Core18 852 4.66 AX.94940605 6D 84.3 6.71 2.01  < 0.01
QPh.niab-6D.1 Ph Full21 2389 4.97 AX.94940605 6D 84.3 6.64 1.58  < 0.01
QYr.niab-4D.1 Yr Core17 253 4.46 AX.94546744 4D 1.4 4.90 − 2.25 7.89
QYr.niab-4D.1 Yr Core18 852 4.66 AX.94546744 4D 1.4 14.27 − 3.93 7.76
QYr.niab-4D.1 Yr Full21 2389 4.97 AX.94546744 4D 1.4 13.82 − 0.78 2.98

The chromosome (Chr.) and physical position (measured in Mb) for each peak marker of each QTL are listed. ‘−log10(P)’ represents the −log10(P-value) for each QTL; ‘Var.’ shows percentage variation explained by each QTL. Significance thresholds (Sig. threshold) were estimated with a Bonferroni-type correction that uses effective markers based on linkage disequilibrium for a corrected P = 0.05. The ‘Alt. allele effect’ represents the dosage of the alternative SHW allele (where ‘Robigus’ was the reference) and ‘n’ was the number of genotypes used in the genetic mapping for each trial